587.65
+2.66%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jubilant Ingrevia
Its shares trade on NSE under the ticker JUBLINGREA.NS. It has been listed since 19 March 2021. In the fiscal year to 31 March 2026, it reported net income of ₹2.78bn. At that date it held total assets of ₹54.84bn and shareholders' equity of ₹31.26bn.
Jubilant Ingrevia Ltd. manufactures chemical products. The company is headquartered in Noida, Uttar Pradesh. The company went IPO on 2021-03-19. The firm's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The firm serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 19 Mar 2021
- Employees
- 2,293
- Website
- jubilantingrevia.com ↗
Leadership
Pay as last reported
- Mr. Hari BhartiaExecutive Co-Chairman of the Board, since 2021₹184.1m
- Mr. Shyam BhartiaNon-Executive Chairman of the Board₹1.5m
- Mr. Varun GuptaPresident, Chief Financial Officer
- Mr. Deepak JainChief Executive Officer, Managing Director, Executive Director, since 2023₹127.7m
- Mr. Ambrish DixitPresident - Speciality Chemicals
- Mr. Vijay SrivastavaChief of Operations, Whole-Time Director₹8.6m
- Ms. Vinita KoulSenior Vice President, Head - Human Resources
- Ms. Deepanjali GulatiCompliance Officer, Company Secretary₹4.9m
- Ms. Aashti BhartiaNon-Executive Non-Independent Director
- Shri. Priyavrat BhartiaNon-Executive Non-Independent Director
- Mr. Pradeep BanerjeeNon-Executive Independent Director₹3.3m
- Ms. Ameeta ChatterjeeNon-Executive Independent Director₹3.3m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 69
- Environment
- 62
- Social
- 99
- Governance
- 46
- Direct emissions (scope 1)
- 895,120 t
- Energy emissions (scope 2)
- 53,320 t
- Value chain emissions (scope 3)
- 797,230 t
- Women in the workforce
- 4.7%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jubilant Ingrevia Ltd employs 2293 full-time employees in Noida, India.
- Speciality Chemicals segment includes pyridine, picolines, and fine chemicals.
- Nutrition and Health Solutions segment offers vitamin B3, B4, and premix formulations.
Weaknesses
- Chemical Intermediates segment focuses on acetyls and speciality ethanol only.
- Agro chemicals business covers insecticides, herbicides, and fungicides only.
- The firm serves pharmaceutical, nutrition, and agrochemical industries exclusively.
Opportunities
- Speciality Chemicals segment can expand into custom development and manufacturing organization.
- Nutrition and Health Solutions segment can grow with animal and human nutrition health solutions.
- Chemical Intermediates segment can leverage acetyls and speciality ethanol for new markets.
Threats
- Agro chemicals business faces competition from insecticides, herbicides, and fungicides manufacturers.
- The firm's reliance on pharmaceutical and nutrition industries poses market risk.
- Chemical Intermediates segment depends on acetyls and speciality ethanol demand fluctuations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.